Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

June 2017 – Cancer Immunotherapy

Immunotherapy the New Frontier in Cancer Treatment
Welcome to the first Special Edition of CONQUER: the patient voice, which focuses on immunotherapies in cancer. With the recent explosion of new immunotherapies being approved by the FDA for the treatment of patients with cancer, and their promise for improvements in survival and reduced adverse events, every patient with cancer should become familiar with these new therapies and the hope they bring to patients, survivors, and their family members. Read More ›

What Is All the Hype About Immunotherapy?
Dr. Bruce Gershenhorn examines the hope that immunotherapy brings to patients, explaining the current medications available, side effects, and future of this promising therapeutic option. Read More ›

Cancer Immunotherapy Drugs Approved by the FDA Since 2015

Why Should I Consider Participating in a Clinical Trial for New Cancer Immunotherapies?
According to the Cancer Research Institute, only 3% to 6% of eligible patients with cancer participate in clinical trials in the United States. Read the reasons why clinical trials are a great option to consider. Read More ›

Immunotherapy for Melanoma: Finding a Response to an Unstoppable Disease
Catherine Poole breaks down the emerging immunotherapy options for Melanoma, not to be confused with the common skin cancers (basal-cell carcinoma and squamous-cell carcinoma) largely caused by exposure to UV rays. Read More ›

Immunotherapy Has Come to Multiple Myeloma
“We are continuing to learn about the ways the immune system interacts with difference types of cancer, including multiple myeloma,” said Dr. Pazdur of the FDA. Read More ›

Recognizing and Treating Immunotherapy Side Effects
Immunotherapy is all the rage today, but like any other treatment, it comes with side effects. Learn how to recognize and manage some of the common side effects. Read More ›

Why Does Immunotherapy Work for Some but Not for Others?
Immunotherapies expose cancer cells to the immune system so it can attack them. Read about why these drugs work so well in some patients but in others the immune system doesn’t respond to these very promising drugs. Read More ›

Immunotherapy Drugs Extend Survival of Patients with Lung Cancer
Check out some of the most exciting immunotherapies that are giving hope to people fighting this disease, which is responsible for 1 in every 4 cancer-related deaths in the United States. Read More ›

New Immunotherapy Drugs Are Making Headway in the Treatment of Bladder Cancer
Take a look at the 5 new promising immunotherapies approved by the FDA for bladder cancer after decades of no new treatment options for this type of cancer. Read More ›